Avidity-controlled biotherapeutic delivery systems for the treatment of ischemia-reperfusion acute kidney injury
Regulatory T cells (Tregs) are key mediators of immune resolution and tissue repair following acute kidney injury (AKI), yet strategies to selectively enri